Literature DB >> 16701972

Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN.

Mohsen Tafaghodi1, S Abolghasem Sajadi Tabassi, Mahmood Reza Jaafari.   

Abstract

In the induction of systemic and mucosal immunity, particulate antigens are more effective than soluble antigens; possibly because they are more efficiently endocytosed by mucosal-associated lymphoid tissue (MALT) M cells. In this study, we determined the systemic and mucosal immune responses in rabbits following intranasal immunization with encapsulated tetanus toxoid (TT) and CpG-ODN in alginate microspheres. The microspheres were less than 4 microm in diameter. Encapsulation efficiency of TT and CpG-ODN was determined as 47.7+/-6.6 and 34.2+/-7.4, respectively. Release of TT and CpG-ODN in a simulated model with nasal cavity was 14.2+/-3.06 and 36.7+/-2.4% after 4 h. Encapsulated TT preserved its intact structure, but its immunoreactivity was decreased to about 91+/-5%. The highest serum IgG and antitoxin, and nasal lavage IgA titers were observed in groups immunized with microsphere formulations. CpG-ODN as an adjuvant could increase the serum IgG and antitoxin titers when co-administered with TT solution, but its co-encapsulation with TT in alginate microspheres failed to potentiate the systemic immune response while induced high IgA titers in nasal lavages. No hemolysis was occurred on incubation of alginate microspheres and human RBCs. Also after nasal administration of plain microspheres to human volunteers, no local irritation was observed. Intranasal administration of microspheres encapsulated with vaccines showed to be an effective way for inducing a variety of immune responses and that a strong systemic IgG and mucosal IgA responses can be induced in rabbits with intranasal administration of alginate microspheres encapsulated with TT.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16701972     DOI: 10.1016/j.ijpharm.2006.03.047

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  15 in total

Review 1.  Applications of alginate microspheres in therapeutics delivery and cell culture: Past, present and future.

Authors:  Dinesh Dhamecha; Rachel Movsas; Ugene Sano; Jyothi U Menon
Journal:  Int J Pharm       Date:  2019-08-14       Impact factor: 5.875

2.  Tetanus toxoid-loaded layer-by-layer nanoassemblies for efficient systemic, mucosal, and cellular immunostimulatory response following oral administration.

Authors:  Harshad Harde; Ashish Kumar Agrawal; Sanyog Jain
Journal:  Drug Deliv Transl Res       Date:  2015-10       Impact factor: 4.617

Review 3.  Innovative strategies for co-delivering antigens and CpG oligonucleotides.

Authors:  Yogita Krishnamachari; Aliasger K Salem
Journal:  Adv Drug Deliv Rev       Date:  2009-01-19       Impact factor: 15.470

Review 4.  Vaccine adjuvants: current challenges and future approaches.

Authors:  Jennifer H Wilson-Welder; Maria P Torres; Matt J Kipper; Surya K Mallapragada; Michael J Wannemuehler; Balaji Narasimhan
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

5.  Alginate Microencapsulation for Oral Immunisation of Finfish: Release Characteristics, Ex Vivo Intestinal Uptake and In Vivo Administration in Atlantic Salmon, Salmo salar L.

Authors:  Bikramjit Ghosh; Barbara F Nowak; Andrew R Bridle
Journal:  Mar Biotechnol (NY)       Date:  2015-09-26       Impact factor: 3.619

Review 6.  Recent progress concerning CpG DNA and its use as a vaccine adjuvant.

Authors:  Hidekazu Shirota; Dennis M Klinman
Journal:  Expert Rev Vaccines       Date:  2013-11-26       Impact factor: 5.217

Review 7.  Marine polysaccharides in microencapsulation and application to aquaculture: "from sea to sea".

Authors:  Massimiliano Borgogna; Barbara Bellich; Attilio Cesàro
Journal:  Mar Drugs       Date:  2011-12-08       Impact factor: 6.085

8.  Mucosal Adjuvant Potential of Quillaja saponins and Cross-linked Dextran Microspheres, Co-administered with Liposomes Encapsulated with Tetanus Toxoid.

Authors:  Faezeh Moghadam Ariaee; Mohsen Tafaghodi
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

9.  The mucosal adjuvant potential of cross-linked dextran microspheres as dry powder.

Authors:  Mohsen Tafaghodi; Maryam Eskandari
Journal:  Iran J Basic Med Sci       Date:  2012-05       Impact factor: 2.699

10.  Alginate nanoparticles as a promising adjuvant and vaccine delivery system.

Authors:  F Sarei; N Mohammadpour Dounighi; H Zolfagharian; P Khaki; S Moradi Bidhendi
Journal:  Indian J Pharm Sci       Date:  2013-07       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.